Sulfonated aluminum phthalocyanine (AlPcS), a widely used photosensitizer for photodynamic therapy of cancer, was conjugated to doxorubicin (Dox), a chemotherapy drug, through electrostatic binding. The fluorescence resonance energy transfer from Dox to AlPcS showed the formation of AlPcS-Dox conjugates, as the fluorescence intensity of conjugated Dox was decreased and that of the AlPcS moiety was enhanced. This AlPcS-Dox conjugation was further confirmed by electrophoresis. The AlPcS-Dox conjugates enhanced the cellular uptake of AlPcS three times more than unconjugated AlPcS in both human hepatocellular carcinoma cell line 7701 and rat basophilic leukemia cell line. Moreover, the photodynamic killing effect of the conjugates was markedly increased as compared with that of AlPcS alone or the cytotoxicity of Dox alone, showing an enhanced effect of the AlPcS-Dox conjugates. These results indicate that the conjugation of a photosensitizer with a chemotherapy drug may improve photodynamic cancer therapy.
Introduction
Mainstream modalities of cancer treatment including chemotherapy have side effects ranging from the unpleasant to the fatal [1, 2] . The chemotherapy modality still faces a huge challenge of reducing the toxicity to normal tissues [3] . Photodynamic therapy (PDT) is a relatively new antitumor technology that involves the use of a tumor-localizing photosensitizer, followed by exposure to light [4, 5] . The combination of chemotherapy with PDT may improve the antitumor effect. Doxorubicin (Dox), a clinically used agent in chemotherapy, is a lipophilic compound with one positive charge [6] . It breaks the DNA chain of tumor cells by terminating DNA replication [7, 8] . Dox is, however, a rather toxic compound with side effects of the gastrointestinal tract and cardiovascular system [9, 10] . Sulfonated aluminum phthalocyanine (AlPcS), one of the so-called second-generation photosensitizers, is widely used in PDT because of its good water solubility, intense absorption band in the red light region (where tissue penetration by light is optimal), and high singlet oxygen yield [11, 12] . However, the negative charges of sulfonated groups (SO 3 -) on the benzene rings of AlPcS decrease its affinity to the cell membrane [3, 13] . In this work, we conjugated the positively charged Dox with the negatively charged AlPcS by an electrostatic force. As Dox is hydrophobic and binds favorably to the cell membrane, AlPcS-Dox conjugates may help enhance the cellular uptake of AlPcS. Further, Dox acts as DNA, whereas AlPcS-mediated PDT targets lysosomes.
The combination of Dox and AlPcS may enhance the photodynamic effect by targeting different sites of cancer cells.
Materials and methods

Preparation and characterization of AlPcS-Dox conjugates
AlPcS and Dox used in this study were purchased from Frontier Scientific Inc. (Logan, Utah, USA) and Shanghai Yi-Li biotechnology Inc. (Shanghai, China), respectively. The chemical structures, with their absorption and fluorescence emission spectra of AlPcS and Dox, are shown in Fig. 1 . The emission peak of AlPcS was at about 690 nm, whereas Dox had two peaks at 550 and 585 nm, measured by a spectrophotometer (F-2500; Hitachi, Tokyo, Japan). As AlPcS has four negative charges and Dox has only one positive charge, different molar concentration ratios (1 : 1 to 1 : 4) of AlPcS and Dox solutions were mixed to prepare AlPcS-Dox conjugates. The solutions were then stirred overnight in a dark room, and the characteristics of these conjugates were measured to calculate an optimal molar ratio of the conjugates for biological experiments.
Detection of singlet oxygen 1,3-Diphenylisobenzofuran (DPBF) can be rapidly oxidized by 1 O 2 into o-dibenzoyl benzene, leading to the degradation of DPBF with a reduced fluorescence intensity [14, 15] . Thus, DPBF is a sensitive probe of 1 O 2 . The solution of AlPcS (4 mmol/l), Dox (8 mmol/l), or AlPcS-Dox conjugate (4 : 8 mmol/l) was mixed with the DPBF solution (12 mmol/l) at an equal volume, respectively. The mixture solutions were then irradiated under a white light of 450-800 nm at a power density of 20 mW/cm 2 for different durations of time. The fluorescence intensities of DBPF in these solutions were measured with a spectrometer (F-2500; Hitachi) using an excitation of 405 nm. The relative 1 O 2 yield of the AlPcS-Dox conjugates was compared with that of unconjugated AlPcS.
Cell culture
The human hepatocellular carcinoma cell line 7701 (QGY) and rat basophilic leukemia cell line (RBL) were obtained from the Cell Bank of Shanghai Science Academy. The cells were seeded in culture dishes containing Dulbecco's modified Eagle's medium medium with 10% calf serum, 100U/ml penicillin, 100 mg/ml streptomycin, and 100 mg/ml neomycin, and incubated in a fully humidified incubator at 371C with 5% of CO 2 . When the cell density reached 80% confluence with a normal morphology, AlPcS, Dox, or AlPcS-Dox was added to the cell dishes, respectively, for a desired period of incubation at 371C. Then cells were washed three times with PBS to remove unassociated drugs and fresh medium was added.
Fluorescence imaging measurements
The fluorescence images of AlPcS, Dox, and their conjugates in the cells were acquired by a laser scanning confocal microscope (LSCM) (FV300, IX71; Olympus, Tokyo, Japan). With the z-scan mode in this system, three-dimensional images can be obtained. A 405 nm laser (Radius, 405-25; Coherent Inc., Santa Clara, California, USA) was introduced into the LSCM as the excitation and a water immersion objective (UplanApo, Â 60, 1.2 NA; Olympus) was used for imaging. As shown in Fig. 1 , as both AlPcS and Dox have a partial absorption at 405 nm, the 405 nm laser was used as the excitation source. The fluorescence signals of cellular Dox were measured in the detection channel 1 with a 505-550 nm band-pass filter and those of cellular AlPcS were collected in the detection channel 2 with a 680-710 nm band-pass filter. The differential interference contrast images were recorded simultaneously in a transmission channel to show the cell morphology.
Cytotoxicity assay
The WST-1 Cell Proliferation and Cytotoxicity Assay Kit (WST-1; Beyotian Biotechnology Institute, Suzhou, China), a new type of MTT kit, was used to measure the phototoxicity/toxicity of the three compounds to cancer cells. The cells at a concentration of 3 Â 10 4 cells/ml were equally seeded in each well of a 96-well flat-bottom tissue culture plate and cultured overnight for their attachment to the plate. AlPcS, Dox, or AlPcS-Dox was then added to different cell wells with final incubation concentrations of 1, 2, and 1 : 2 mmol/l, respectively. After a 6-h incubation, the cells were washed three times with PBS to remove the unbound compounds, and fresh medium was added. The cells were then irradiated for 50 min by a white light source at a power density of 20 mW/cm 2 , and then incubated for 12 h. The mixture of 10 ml WST-1 solution (5 mg/ml) and 100 ml fresh medium was added to each well for another 2 h of incubation. The 96-well plate was finally placed in an iEMS Analyzer (Lab-system; Pu-Lang New Technique Inc., Beijing, China) and the optical densities at 450 nm for each well were measured to determine the cell viability as compared with that of untreated control cells in the same plate. All results were presented as the mean±SD from three to five independent experiments, with six wells in each.
Results and discussion
The characterization of AlPcS-Dox conjugates
The structure of AlPcS-Dox conjugation is shown in Fig. 1 . The energy transfer may occur between AlPcS and Dox through the conjugation. The fluorescence resonance energy transfer (FRET), a sensitive way to characterize the binding of a pair of molecules, was used to check the conjugates [16] . As shown in Fig. 1 , the AlPcS has two absorption bands. One is the Q band around 670 nm and the other is the Soret band in the near-UV region (350 nm). The Dox has an absorption band of 490 nm and a broad emission band from 550 to 630 nm. The emission band of Dox overlaps with the absorption Q band of AlPcS, fulfilling the FRET requirement of the donor-acceptor pair [17] . Figure 2a shows the emission spectra of AlPcS, Dox, and their conjugates in aqueous solutions under an excitation of 490 nm. As compared with the emission intensities of unconjugated AlPcS and Dox, the emission intensity of AlPcS-Dox around 590 nm band decreased with a marked increase in its emission intensity of 690 nm, showing a typical FRET model of the energy transfer from the Dox (donor) to the AlPcS (acceptor). On the basis of the FRET enhancements at the 690 nm emission band of AlPcS-Dox conjugates, the solutions with different molar ratios of AlPcS-Dox from 1 : 1 to 1 : 4 were measured to determine an optimal ratio of 1 : 2.
Electrophoresis experiment
Electrophoresis was used to evaluate whether AlPcS was conjugated to Dox through the electrostatic binding. As AlPcS has four negative charges and Dox has one positive charge, the AlPcS-Dox (1 : 2) conjugates have two net negative charges and thus move toward the positive pole of the electrophoresis pool. As shown in Fig. 2b , AlPcS migrates a long distance toward the positive pole and Dox moves a short distance toward the negative pole. The AlPcS-Dox conjugates are at a position about half the distance of that of AlPcS toward the positive pole, confirming the formation of the AlPcS-Dox conjugates.
Singlet oxygen measurements
DPBF has a typical emission band from 440 to 520 nm. When DPBF is degraded, the fluorescence intensity of its (Fig. 3b ).
Cellular uptake of AlPcS-Dox
After a 6-h incubation, a larger concentration of Dox (20 mmol/l) was taken up by both QGY and RBL cells ( Fig. 4a1 and c1 ), but weak cellular AlPcS fluorescence was found in the two cell lines (Fig. 4a2 and c2) . Interestingly, the AlPcS fluorescence intensity was markedly increased when cells were incubated with the AlPcS-Dox (10 : 20 mmol/l) conjugates ( Fig. 4b2 and d2 ) in the QGY and RBL cells, indicating that this conjugation can enhance the cellular delivery of AlPcS. Further, Fig. 4b1-b3 shows that most AlPcS and Dox are still bound together in the QGY cells because the subcellular localization pattern of AlPcS is well overlapped with that of Dox. The same observation was also made in the RBL cells ( Fig. 4d) . Quantitatively, the cellular amount of AlPcS in the AlPcS-Dox (10 : 20mmol/l)incubated QGY cells is on average three times higher than that of unconjugated AlPcS (10 mmol/l) incubated QGY cells. This finding was confirmed using a three-fold higher concentration of AlPcS (30 mmol/l) with a fluorescence intensity ( Fig. 4a3 ) comparable to that of AlPcS in Fig. 4b2 . The AlPcS-Dox conjugation also enhanced the cellular uptake of AlPcS in the RBL cells with a factor of around 4 ( Fig. 4c and d) , indicating that the AlPcS-Dox conjugation may be a feasible carrier for the intracellular delivery of AlPcS.
Photodynamic therapy effects of AlPcS-Dox conjugates
AlPcS-mediated PDT is known to be efficient at killing tumor cells, whereas Dox is an effective chemotherapeutic agent. The aim of this study was to investigate whether the AlPcS-Dox conjugates can improve the efficacy of AlPcS-PDT. The concentrations of 2 mmol/l for Dox and 1 mmol/l for AlPcS were used in the QGY cells to obtain the optimal ratio of 1 : 2. In addition, a concentration of 3mmol/l for AlPcS was included for comparison, as AlPcS-Dox conjugates can deliver AlPcS to cells three times higher than unconjugated AlPcS. Similarly, 1 and 4 mmol/l concentrations of AlPcS were used in the RBL cells. Figure 5a shows the killing effects of different compounds on the QGY cells. PDT with 1 or 3 mmol/l AlPcS plus light irradiation (1A + L or 3A + L) killed about 10 and 20% of cells, respectively, whereas 2 mmol/l Dox (2D) resulted in 20% cell death. When cells were incubated with AlPcS-Dox (1 : 2 mmol/l) conjugates, followed by the light irradiation (1A + 2D + L), more than 60% of the cells were killed, indicating a synergistic effect of the AlPcS-PDT in combination with the cytotoxicity of Dox. Similar results were also found in the RBL cells. This effect may be because of the different targets of AlPcS-PDT and Dox in the cells.
Conclusion
The conjugates of AlPcS-Dox can be prepared simply by electrostatic binding. Such conjugates are taken up by the QGY and RBL cell lines more easily than unconjugated AlPcS, thus enhancing the intracellular delivery of AlPcS. The increased cellular delivery of AlPcS leads to more efficient cell killing because of a synergistic effect of the AlPcS-PDT-mediated and Dox-mediated cytotoxicity. This finding indicates that the conjugation of a photosensitizer to a chemotherapeutic compound can improve photodynamic cancer therapy. 
